![]()
|
|
||||||||
(Received for publication, June 25, 1996, and in revised form, August 5, 1996)
From the The members of the
Ultracentrifugation and circular dichroic spectroscopy reveal that MRP
is an elongated protein, with an axis ratio estimated between 7 and 12 and with an apparent random coil conformation. MRP binds to CaM
with high affinity (Kd,myr = 4 nM; Kd,unmyr = 7 nM) and with a second order rate constant,
k+1,unmyr, of 1.6 × 108
M Finally, unmyr MRP can be stoichiometrically myristoylated by
N-myristoyl transferase in vitro. Since neither
binding of CaM nor phosphorylation by PKM inhibits myristoylation, the
N terminus of unmyr MRP is exposed on the surface of the protein and is
well separated from the effector domain. In view of the observations
that unmyr and myr MRP do not exhibit significant differences in their
properties in solution, the function of myristoylation is most probably
to modulate the interactions of MRP with membranes.
Proteins of the MARCKS1 family are
protein kinase C (PKC) substrates that are phosphorylated during major
cellular events such as neurosecretion, fibroblast mitosis, and
macrophage activation (1, 2). The N-terminal glycine residue of MARCKS
proteins is myristoylated through a reaction catalyzed by myristoyl
CoA:protein N-myristoyltransferase (NMT) (3, 4). Studies
with acylated peptides as well as with the intact protein suggest that
the myristoyl moiety is involved in membrane binding (5, 6, 7, 8, 9). MARCKS
proteins also contain a highly basic domain, the phosphorylation site
(PS) domain, which is phosphorylated following activation of cellular
PKC with phorbol esters (10), which binds with high affinity to
calmodulin (CaM) in the presence of calcium (Ca2+) (11) and
which cross-links actin filaments in vitro (12).
Phosphorylation of serine residues in the PS domain regulates these
interactions by disrupting the MARCKS-calmodulin complex (11), by
inhibiting the actin filaments cross-linking activity of MARCKS (12)
and by decreasing the affinity of the PS domain for negatively charged
membranes such as the plasma membrane (13). These molecular properties
have led to the proposal that MARCKS proteins might modulate the
function of CaM by decreasing the cytoplasmic concentration of free
CaM. MARCKS proteins might also regulate the plasticity of the
cytoskeleton by cross-linking actin filaments at the membrane (1). Such
models imply dynamic, highly regulated interactions of MARCKS proteins
with membranes and other proteins. In order to test these
hypotheses a detailed understanding of the thermodynamics and kinetics
of these interactions is required.
The MARCKS family comprises two members: MARCKS is an acidic ubiquitous
rod-shaped 32-kDa protein; MARCKS-related protein (MRP, also MacMARCKS
or F52) is a 20-kDa protein that has 50% homology to MARCKS and is
predominantly expressed in brain and reproductive tissues (14, 15).
Whereas MARCKS has been relatively well characterized, only a few
reports describe the molecular properties of MRP in vitro
(8, 11, 16, 17). The recent findings that MRP is essential for brain
development (15) and phagocytosis (18) and that MRP has a different
subcellular localization than MARCKS (19) further emphasize the need
for characterizing MRP.
Recently, the concept of myristoyl switch has emerged. Some
myristoylated proteins may sense a signal, such as calcium for
recoverin (20) or GTP for the ADP-ribosylation factor (21), which
induces a conformational change that exposes the myristoyl moiety and
allows binding of these proteins to membranes. McLaughlin and Aderem
(22) have proposed that phosphorylation/dephosphorylation events might
be the signals that trigger the myristoyl switch in MARCKS proteins.
Alternatively, Ca2+/CaM might also be a candidate to
trigger such a switch in MARCKS proteins.
In order to gain insight into the aforementioned aspects, namely
regulation of the interactions of MARCKS proteins with other proteins,
characterization of MRP, and characterization of a putative myristoyl
switch, we have investigated the structure of MRP as well as its
interactions with CaM, with the catalytic subunit of PKC (PKM), and
with NMT. How myristoylation affects the behavior of MRP in solution
was also explored by comparing the properties of unmyristoylated
(unmyr) and myristoylated (myr) MRP.
Recombinant mouse unmyr and myr MRPs were
expressed in Escherichia coli and purified, using a mild
procedure that does not use heating and acid treatment (8). Rat brain
PKM was purchased from Calbiochem. Calf brain PKM was prepared by
limited trypsinolysis of purified PKC (23, 24). Bovine brain CaM,
5-dimethylaminonaphthalene-1-sulfonyl-calmodulin (CaMD),
and calf thymus histone (Type III-SS) were purchased from
Sigma (Fluka Chemie, Buchs, Switzerland). Purified MRP
was stored at Sedimentation velocity and
sedimentation equilibrium runs of unmyr MRP were performed in an XLA
Optima analytical ultracentrifuge (Beckman Instruments) equipped with
UV absorption optics and a photoelectric scanning system. The
absorbance (A) was measured at 230 nm. Sedimentation
equilibrium runs were performed at 20 °C at 22,000 rpm in a 12-mm DS
charcoal cell. The molecular weight was calculated using a linear
regression program obtaining the best linear fit of ln A versus
r2, where r is the distance from the rotor
center (25).
Sedimentation velocity runs were performed at 20 °C and 46,000 rpm
in a Beckman An60 Ti rotor 316 using a 12-mm DS Epon cell. The
relatively low amounts of MRP available, as well as its tendency to
oligomerize, precluded experiments in a wide range of protein
concentrations. The sedimentation coefficient
(s20,w) does not depend on the
concentration of MRP in the low range of concentrations studied
(0.2-0.8 mg/ml MRP). We have therefore used an average of seven
values, determined in this concentration range, as an approximation for
the sedimentation coefficient extrapolated at infinite dilution of
protein (20,w0).
The diffusion constant (D) was calculated from the
equation,
Volume 271, Number 43,
Issue of October 25, 1996
pp. 26794-26802
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
§,
,
and
''
Department of Biophysical Chemistry,
Biozentrum, University of Basel, Klingelbergstrasse 70, 4056 Basel,
Switzerland, the ¶ Medical Research Council, Anatomical
Neuropharmacology Unit, Department of Pharmacology, University of
Oxford, South Parks Road, Oxford OX1 3TH, United Kingdom, and
INSERM CJF 95-10, CHU Purpan, 31059 Toulouse, France
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
yristoylated
lanine-
ich
inase
ubstrate (MARCKS) family
are proteins essential for brain development and phagocytosis. MARCKS
proteins bind to actin filaments and calmodulin (CaM) and are
phosphorylated by protein kinase C. In order to investigate how these
interactions are regulated, we have characterized the properties of
both the myristoylated (myr) and unmyristoylated (unmyr) forms of
recombinant MARCKS-related protein (MRP), a 20-kDa member of the MARCKS
family.
1 s
1. In contrast to classical
ligands such as the myosin light chain kinase, binding of MRP to CaM
does not induce the formation of an
-helix in MRP. The catalytic
subunit of protein kinase C (PKM) phosphorylates myr MRP with high
affinity ([S]0.5 = 3.5 µM), positive
cooperativity (nH = 2.5) and a turnover number
of 130 min
1. CaM inhibits the phosphorylation of myr MRP
with a half-maximum rate of phosphorylation at a [CaM]/[MRP] ratio
of 0.7, indicating that CaM might efficiently regulate the
phosphorylation of MRP in vivo. Interestingly,
Ca2+ inhibits the binding of MRP to CaM as well as its
phosphorylation by PKM in the millimolar concentration range,
suggesting that MRP has a weak affinity for Ca2+.
Proteins
80 °C in 10 mM MOPS, pH 7.4, 0.1 mM EGTA. Unless stated otherwise, all measurements were
performed in buffer A (10 mM MOPS, pH 7.4, 100 mM NaCl, 0.001% Triton X-100) containing 0.1 mM EGTA. Triton X-100 was added to minimize the adsorption
of MRP on the surfaces of the tubes and cuvettes. This concentration of
detergent improved the reproducibility of the experiments without
affecting the data.
where R is the gas constant, T is the
absolute temperature, M is the molecular weight of MRP
calculated from the cDNA sequence of MRP (20,165 g/mol),
(Eq. 1)
is the
partial specific volume of MRP calculated from the amino acid
composition (0.705 cm3/g), and
is the solvent density
(1.003 g/cm3) (26). The parameters describing the geometry
of MRP were calculated according to Laue et al. (26) and
Byers and Kay (27). Briefly, the experimental Stokes radius
(RS) was calculated from the following,
where N is Avogadro's number and
(Eq. 2)
o is the
solvent viscosity (1.02 g·m
1·s
1). The
translational frictional ratio, f/f0,
was calculated from the following,
where R0 is equal to 1.8 × 10
(Eq. 3)
7 cm and is the Stokes radius of the equivalent
unhydrated sphere of molecular weight M and partial specific
volume
. The axial ratio for a prolate ellipsoid was estimated from
the frictional ratio using the power series,
where a is the long axis length (nm), b is
the short axis length (nm), and X is equal to
(f/f0
(Eq. 4)
1). This calculation does
not take into account hydration effects and gives a maximal axis ratio,
(a/b)p,max. A minimal value
for the axis ratio,
(a/b)p,min, can be estimated
assuming maximal hydration of the protein and substituting X
in Equation 4 as follows,
where
(Eq. 5)
1 is the degree of hydration estimated from
the amino acid composition of MRP (0.539 g of H2O/g of
protein) (28). Finally, the absolute values for a and
b were evaluated from the following.
(Eq. 6)
Circular dichroic (CD)
spectra were recorded in a Jasco 720 spectropolarimeter equipped with a
thermostated quartz cell (1-mm path length) or a double chamber quartz
cell (1-cm path length) (Hellma, Mühlheim, Germany). Each
spectrum, including the base line, was recorded several times and
averaged. The maximal
-helical content of the spectra
(f
) was calculated from the mean residue
molar ellipticity,
(deg·cm2·dmol
1·residue
1),
at 222 nm according to Ref. 29.
|
(Eq. 7) |
Binding of MRP to CaMD was performed at 22 °C in a Jasco FP-777 fluorometer (Japan Spectroscopic Co., Ltd., Tokyo, Japan) as described previously (16, 30). The measurements were performed in quartz cuvettes with a 1-cm path length (Hellma). CaMD fluorescence was excited at 340 nm, and the emission was measured at 480 nm. The signal was corrected for the contribution of buffer. Unless stated otherwise, the measurements were performed in buffer A containing 0.1 mM CaCl2.
In analogy to the function used to describe the dissociation constant (Kd) for a 1:1 complex between MRP and CaMD (31),
|
(Eq. 8) |
|
(Eq. 9) |
|
(Eq. 10) |
[CaMD·MRP]. A comparison of Equations 9 and 10 shows
that the following holds true.
|
(Eq. 11) |
|
(Eq. 12) |
The kinetics of binding of unmyr MRP to CaMD were measured at 22 °C in a Durrum stopped-flow fluorometer equipped with a mercury-xenon lamp. The instrument was modified to increase its sensitivity as described (32); its dead time was determined to be 4.5 ms. Excitation was at 334 nm. Emission was detected over 435 nm using a cut-off filter. The average from at least five kinetic traces was fitted by the sum of two exponential functions and analyzed as described for the binding of myosin light chain kinase (MLCK) (33). The experiments were conducted in buffer A containing 0.1 mM CaCl2.
Phosphorylation of MRP by PKMThe initial rates of
phosphorylation of MRP were measured at 30 °C in buffer A containing
0-6.3 µM MRP, 0.5 nM PKM, 0.1 mM
[
-32P]ATP (0.2 µCi), 0.1 mM
CaCl2, and 6 mM MgCl2 in a final
volume of 20 µl. Under these conditions, the phosphorylation rates
were linear during the first 30 min (not shown). The reactions were
stopped after 20 min by adding 5 µl of SDS sample buffer (50 mM Tris, pH 6.8, 10% glycerol, 0.2% SDS, 0.02%
bromphenol blue) and heating at 95 °C for 3 min. MRP was separated
from excess [
-32P]ATP on 12.5% SDS-polyacrylamide
gels. The radioactivity associated with MRP was quantified by overnight
exposure of the dried gels to a storage phosphor screen and by scanning
the screen in a PhosphorImager (Molecular Dynamics). The
stoichiometry of phosphorylation was calculated by exposing the gels
containing phosphorylated MRP simultaneously with a nitrocellulose
membrane on which known amounts of [
-32P]ATP (0-30
pmol in 5 µl) were spotted. The conditions (amount of radioactivity
and exposure time) were chosen such that the signal arising from
phosphorylated MRP and from the calibration curve was in the linear
range. The kinetic data were analyzed with the Hill equation
(34),
|
(Eq. 13) |
For phosphopeptide analysis, MRP was phosphorylated as described above except that the PKM concentration was raised to 2.5 nM and the incubation time to 2.5 h. The MRP concentration was 5 µM. Following electrophoretic transfer of phosphorylated MRP to nitrocellulose, MRP was digested with trypsin, and the corresponding phosphopeptides were separated by thin layer chromatography as described (11).
In Vitro MyristoylationPolyhistidine-tagged human NMT expressed in E. coli was purified as described previously (35). The in vitro incubations were performed using 36 nM NMT, 0.6 µM unmyr MRP, 10 µM myristoyl-CoA (1.2-1.5 × 106 dpm) and 0.5-2.5 µM CaM for 10 min at 30 °C in a final volume of 50 µl of buffer A. The incubations were terminated by the addition of 50 µl of 2 × SDS-sample buffer and heating to 100 °C for 2 min. Samples of each incubation (50 µl) were analyzed by SDS-polyacrylamide gel electrophoresis, and the positions of the bands were identified by fluorography using diphenyloxazole as described (36). Following fluorography, the extent of labeling was determined by volume scanning densitometry using a Computing Densitometer model 300A (Molecular Dynamics). For stoichiometry determinations, the fluorograph was used to localize the radiolabeled bands on the gel. These were excised and rehydrated for 30 min at room temperature, and the diphenyloxazole was removed by two 30-min treatments with dimethylsulfoxide (5 ml). The cleared gel was macerated, transferred to a screw-topped scintillation vial, and incubated with 0.5 ml of Soluene-100 (Packard Instrument Co.) for 24 h at 37 °C. The released radioactivity was determined by scintillation counting using 5 ml of Liquiscint (National Diagnostics).
Data AnalysisThe data obtained from CD spectroscopy and fluorometry, as well as from scanning of the radioactive phosphorylation and myristoylation experiments, were transferred to the SigmaPlot program (Jandel Scientific, San Rafael, CA) and analyzed using the appropriate functions.
Following expression in E. coli, recombinant mouse MRP was purified to homogeneity (8). The protein has an amino acid composition that correlates well with the sequence deduced from the cDNA (37). The concentrations of myr and unmyr MRP were routinely determined by the Lowry assay using bovine serum albumin as a standard (38). The concentrations obtained with this assay were divided by a factor of 1.6, since amino acid analysis showed that the Lowry assay overestimates the concentration of MRP. Assays based on the method of Bradford (39) are inappropriate, since they overestimate the MRP concentrations by a significantly higher factor of about 10.
Hydrodynamic Properties of MRPIn the absence of x-ray and NMR data, our knowledge about the structure of MARCKS proteins is rather limited. To gain insight into the structure of unmyr MRP, we have investigated its hydrodynamic properties in an analytical ultracentrifuge. In the range of concentrations analyzed (0.2-0.8 mg/ml), the majority of the unmyr MRP molecules (>60%) has an estimated molecular mass of 21 kDa. Since the mass calculated from the amino acid composition of the protein is 20.2 kDa, most of the unmyr MRP molecules are monomeric. A significant fraction of protein (10-40%, depending on the experiments) has, however, molecular weights corresponding to dimers and/or higher aggregates. These populations could not be separated in the ultracentrifuge. Hence, the nature as well as the distribution of these oligomers remain to be determined. That unmyr MRP can oligomerize is important with respect to the actin filament cross-linking activity of MARCKS proteins (12). To cross-link actin filaments, MARCKS proteins must either have two binding sites for actin filaments or dimerize. Since only one binding site has been identified so far, namely the PS domain, our results suggest that dimerization of MRP might be physiologically relevant.
Because monomeric unmyr MRP could be separated from the oligomers, hydrodynamic and structural parameters could be determined for the monomeric population. The results of this analysis are shown in Table I. An unusually high frictional ratio can be calculated from the sedimentation coefficient of unmyr MRP, indicating that the protein has an elongated structure. Assuming the form of a prolate ellipsoid, we can calculate that the axis ratio (a/b)p ranges between 6.8 and 12.1, depending on the hydration of the protein. Since unmyr MRP is elongated and contains a large proportion of polar residues, the protein is probably highly hydrated, and the axis ratio of 6.8 better describes its geometry. Using this ratio, we can estimate that the molecular dimensions of unmyr MRP monomers are 1.9 nm × 12.9 nm. For comparison, electron micrographs of the 30-kDa MARCKS reveal rods with dimensions of 3.7-5.1 nm × 35.6 nm (12).
|
||||||||||||||||||||||||||
To obtain further information on
the structure of unmyr and myr MRP we have measured its CD spectrum.
Fig. 1 shows that the secondary structure of MRP is not
dominated by classical secondary structure elements such as
-helices
or
-sheets and is reminiscent of a random coil structure. A
maximal
-helical content of 15% can be calculated at 222 nm from Equation 7, a value similar to that obtained for MARCKS (40).
The additional 100 amino acid residues present in MARCKS are therefore
unlikely to add important elements of secondary structure to the
protein. This conclusion is in agreement with the observation that
these additional residues are scattered through the entire MARCKS
primary sequence.
Binding to other proteins and to membranes, as well as
post-translational modifications such as phosphorylation might
stabilize or induce the formation of elements of secondary structure in
MRP. The question of whether MRP has a potential for such
conformational changes was addressed by measuring CD spectra of the
protein in the presence of the
-helical inducers trifluoroethanol
(TFE) and hexafluoroisopropyl alcohol (HFIP) (41, 42). Fig.
2A shows that TFE has a significant effect on
the CD spectra of myr MRP. A difference spectrum between solutions
containing 69% and 0% TFE clearly demonstrates that TFE induces the
formation of
-helices (minima at 208 and 222 nm) (Fig.
2B). To further characterize this effect, MRP was titrated
with increasing concentrations of TFE and HFIP (Fig. 2C).
The ratio
222 nm/
208 nm is an index for
the
-helicity of proteins and is 1.1 for an ideal
-helix (43).
HFIP increases the
-helicity of MRP at significantly lower
concentrations than TFE. Interestingly, the curve reaches a plateau at
about 30% HFIP. This observation suggests that an equilibrium exists
between the random coil conformation of MRP in aqueous solution and an
-helical conformation, which is stabilized by HFIP. Is such an
-helical conformation physiologically relevant? HFIP and TFE have
been proposed to stabilize secondary structures in peptides and
proteins by modifying the physicochemical properties of their
surrounding (41). Although this concept has recently been questioned
(44), these solvents might mimic situations in which the surface
properties of proteins are significantly modified. With this hypothesis
in mind, we would predict that binding of MRP to other proteins or to
membranes might induce a drastic increase in the
-helical content of
the protein. This hypothesis is attractive, since we have recently
found kinetic evidence that MRP binds at the surface of planar membrane
bilayers with different conformations.2 To
further investigate this phenomenon, the binding of MRP to lipid
vesicles should therefore be measured by CD spectroscopy. However,
since MRP has a significantly lower affinity for lipid vesicles than
the peptide corresponding to the PS domain of MARCKS (8, 45), such an
analysis might be complicated by the scattering of the vesicular
suspensions.
-helices in MRP.
A, CD spectra of myr MRP in the presence of 10%
(upper spectrum) and 69% (lower spectrum) TFE.
B, CD spectrum of myr MRP resulting from subtraction of the
spectrum of myr MRP in 0% TFE from the spectrum in 69% TFE.
C, titration of myr MRP with increasing concentrations of
TFE (
) and HFIP (
). The ratio
222 nm/
208 nm is an index for the
-helical content. myr MRP (1 µM) was in buffer A with
0.1 mM EGTA.
The solubility of MARCKS proteins at high temperature and low pH has been widely used as a tool for their purification (15, 46). Whether these treatments alter the secondary structure of these proteins has not yet been determined. To investigate this aspect we have heated MRP solutions to 95 °C or decreased their pH to 4.0. These treatments have small but reversible effects on the CD spectra, suggesting that MRP not only remains soluble but also retains its structure when exposed to these harsh conditions (not shown).
Binding of MRP to CaMBinding of MRP to CaMD
induces a shift (500-490 nm) as well as an increase (1.8-2.5-fold) in
the fluorescence emission maximum of the dansyl group covalently bound
to the N terminus of CaM (8, 11, 16). These properties were used to
determine the dissociation constant of the complex by titrating
CaMD with MRP, as shown in Fig. 3.
Typically, half-maximum saturation of the fluorescence signal is
reached at a ratio [MRP]/[CaMD] slightly above 0.5, indicating that MRP binds to CaM in a 1:1 ratio. The data were thus
fitted with an hyperbolic function, assuming a noncooperative
interaction between MRP and CaMD and a 1:1 stoichiometry
(see ``Experimental Procedures''). In Fig.
4A, the apparent dissociation constants
calculated from these curves are plotted as a function of
[CaMD]. Fitting the data with a linear regression and
extrapolating the apparent dissociation constants to
[CaMD] equal to zero give the dissociation constants of
the complexes with myr MRP (kd = 4 ± 1 nM) and unmyr MRP (Kd = 7 ± 2 nM). The slopes of the linear regressions are close to the
theoretical value of 0.5 described in Equation 12 (0.55 for unmyr MRP
and 0.65 for myr MRP), indicating that, in the CaMD
concentration range shown in Fig. 4A, MRP binds to
CaMD as a 1:1 complex. The dissociation constant for unmyr
MRP is close to the value published for the same protein purified by
heat and acid treatment (Kd = 9.5 nM)
(11). Hence, heating or acidifying MRP solutions does not alter the
affinity of the protein for CaMD. Interestingly, if
[CaMD] is increased above 40 nM, the apparent
dissociation constants deviate from the linear relationship observed at
lower concentrations (Fig. 4B). This behavior might result
from the tendency of the protein to oligomerize (see ``Hydrodynamic
Properties of MRP''). The apparent dissociation constants seen at
higher concentrations may therefore reflect the affinity of MRP
oligomers for CaMD. Alternatively, MRP oligomers may not
bind to CaMD; the concentrations of monomers, and
consequently the apparent dissociation constants, would then be
overestimated. In this respect, evidence was found for the binding of
two molecules of MLCK on CaM (47). Since the intracellular
concentrations of MARCKS proteins (12 µM) and CaM (60 µM) (2) are well above the concentrations presented in
Fig. 4B, these oligomerization effects might be
physiologically relevant and merit further analysis.
, unmyr
MRP;
, myr MRP. The proteins were in buffer A with 0.1 mM CaCl2.
, unmyr MRP;
, myr MRP. B, high concentrations of
CaMD.
, unmyr MRP. The proteins were in buffer A with
0.1 mM CaCl2. Each data point is the average
from at least three measurements.
In order to understand their mechanism of recognition we have investigated the kinetics of binding of unmyr MRP to CaMD using stopped-flow fluorescence spectroscopy. A typical kinetic trace is shown in Fig. 5A. Although the binding is apparently monophasic, a careful analysis of the kinetic trace indicates the presence of a second phase, whose amplitude is about 10% of the total fluorescence signal. Consequently, the data were fitted with the sum of two exponential functions. The validity of this analysis can better be appreciated in Fig. 5B, which shows that the residuals of the fitting do not significantly deviate from the zero line. Fig. 5C plots the observed association rate constants kobs1 and kobs2 as a function of [unmyr MRP]. While kobs1 is a second order rate constant, which depends on [unmyr MRP], kobs2 is a first order rate constant, which is independent of [unmyr MRP]. Based on these observations, we propose the following scheme for the binding of unmyr MRP to CaM,
|
|
|
(Eq. 14) |
|
(Eq. 15) |
1, k+2, and
k
2. From the slope of the upper
line shown in Fig. 5C, we can determine the second
order rate constant k+1. This value
(k+1 = 1.6 × 108
M
1 s
1) is similar to the value
estimated for MLCK (k1 = 1.1 × 108 M
1 s
1).
kobs2 is a constant equal to (11 ± 4)
s
1, which is the sum of the first order rate constants
k+2 and k
2. For
comparison, an 8-fold slower rate constant was estimated for the
isomerization of the complex between MLCK and CaM
(k2 + k
2 = 1.3 s
1) (33). In analogy to the model of Török
and Trentham, kobs1 reflects the formation of
the initial complex between MRP and CaMD, while
kobs2 describes reorganization of the
MRP·CaMD complex. Keeping in mind that MRP oligomerizes
and that this oligomerization might affect the affinity of the protein
for CaM, kobs2 might also describe a structural
rearrangement involving MRP oligomers at the CaM binding site.
,
kobs1; the data were fitted with a linear
regression (solid line) to obtain the association rate
constant k+1.
, kobs2.
The dotted line represents the average of these values. The
proteins were in buffer A with 0.1 mM CaCl2.
Each value represents the average from at least five kinetic
traces.
One hallmark of most CaM-binding domains is their tendency to bind to
CaM as amphipathic
-helices. Whether these domains are already
-helical in the unbound state or whether binding induces the
formation of these
-helices, as shown with many peptides, is still a
matter of debate (48, 49, 50). Since unbound MRP has only a low
-helical
content in solution (see Fig. 1) and since the amino acid sequence of
the effector domain of MRP (the PS domain) can potentially form a basic
amphipathic
-helix (1), binding of MRP to CaM might induce the
formation of an
-helix in the PS domain. We have therefore
investigated the effect of complex formation on the secondary structure
of CaM and MRP. In contrast to the organic solvents HFIP and TFE (see
Fig. 2), CD spectroscopy shows that the binding of CaM to MRP has no
observable effect on the overall secondary structure of the proteins
(Fig. 6). Since studies with spin-labeled peptides
indicate that the PS domain has an extended structure in solution (51),
our results suggest that this PS domain is not in an
-helical
conformation in the MRP·CaM complex. Hence, MRP might belong to
a family of CaM ligands that do not follow the
-helical model. In
this respect, proteins believed to contain a sequentially discontinuous
CaM-binding domain, such as phosphorylase kinase,
Ca2+-ATPase, and caldesmon, do not seem to form
-helices
when bound to CaM (49).
Phosphorylation of MRP
Phosphorylation is central to the regulation of the function of MARCKS proteins. This event is generally associated with a reorganization of the subcellular localization of MARCKS proteins (19). Phosphorylation of MARCKS proteins has also been proposed to regulate the structure of the actin cytoskeleton (12) as well as the concentration of free cytosolic CaM (2, 52).
Phosphorylation of myr MRP has not yet been investigated. In contrast
to PKC, PKM does not require lipids for its activation (53). This
property makes it a suitable enzyme to study the solution properties of
MRP. Fig. 7 shows the kinetics of phosphorylation of
unmyr (Fig. 7A) and myr (Fig. 7B) MRP by PKM.
Since the data could not be fitted assuming a noncooperative
Michaelis-Menten model, we have used the Hill equation in which
cooperativity is expressed by the Hill coefficient (see Equation 13).
The kinetic parameters resulting from this analysis are shown in Table
II. myr MRP is phosphorylated with high affinity
(S0.5 = 3.5 µM) and positive cooperativity.
This cooperative behavior might result from the phosphorylation of two
serine residues in the PS domain (11). A thin layer chromatography of
phosphopeptides generated by trypsinolysis shows two labeled peptides
of equal intensities, confirming that two serines are indeed
phosphorylated in MRP. Alternatively, our data with ultracentrifugation
and with CaMD binding (see ``Hydrodynamic Properties of
MRP'' and ``Binding of MRP to CaM'') indicate that cooperativity
might result from oligomerization of MRP. Note that the turnover number
(kp = 130 min
1) is relatively large
compared with other substrates, such as histones H1 for which PKM has a
turnover number of about 40 min
1 (according to the
Calbiochem product data sheet). MRP can thus be considered as an
efficient substrate for PKM.
|
|||||||||||||||
A comparison of our data with the results previously published for unmyr MRP (S0.5 = 238 nM) (11) shows that our S0.5 value is significantly larger. Since the concentration of MRP was determined by the Lowry assay in that study, the value of 238 nM is overestimated by a factor of 1.6 (see ``Determination of the Concentration and Amino Acid Composition of MRP''). The affinity of our protein for PKM is therefore 16-fold lower. This discrepancy does not result from the fact that Verghese and colleagues have purified unmyr MRP by heat and acid treatment, since these treatments do not significantly change the kinetic parameters of our protein (not shown). We have also compared two preparations of PKM (see ``Experimental Procedures'') and found no significant differences in the phosphorylation of MRP (not shown). Having excluded these possibilities, the reason for this difference remains unknown.
MARCKS proteins have been proposed to serve as a reservoir for CaM (2).
Since CaM does not bind to phosphorylated MARCKS proteins, it has also
been suggested that PKC could regulate the level of free CaM by
phosphorylating MARCKS, thus leading to the release of CaM (2). Several
reports show that CaM inhibits the phosphorylation of MARCKS (54, 55)
and MRP (15) in vitro. Experimental evidence that CaM
inhibits MARCKS phosphorylation in vivo was also recently
obtained in keratinocytes and glioma cells (56, 57). MARCKS proteins
would consequently allow a cross-talk between PKC and
Ca2+/CaM-dependent signal transduction pathways
(2, 52). An understanding of the regulation of these interactions
requires an analysis of the stoichiometry of the
CaM-dependent inhibition of MRP phosphorylation. To
investigate this aspect we have quantified the effect of CaM on the
phosphorylation rates of MRP. Fig. 8 shows that the rate
of phosphorylation of myr MRP can be efficiently inhibited by CaM with
a half-maximum CaM/MRP ratio of 0.7 at 1 µM MRP. Since
the subcellular concentration of CaM is in sufficient excess over MRP
(2), our results indicate that CaM should also efficiently inhibit the
phosphorylation of MRP in vivo.
Since PKC phosphorylates its substrates at the membrane surface (53) and since CaM most probably binds to cytosolic, but not to membrane-bound, MARCKS proteins (58),2 CaM might act as a chaperone that can protect newly synthesized MRP from undesired phosphorylation by cytosolic kinases, therefore allowing the protein to reach its correct subcellular localization. In this respect, it is interesting to note that MARCKS proteins can serve as substrates for proline-directed protein kinases (59, 60).
In Vitro Myristoylation of MRPN-terminal myristoylation of
proteins is normally a co-translational event (61). Post-translational
myristoylation of MARCKS proteins might, however, be relevant in
vivo, since a pool of unmyristoylated MARCKS is present in brain
(62, 63) and since a demyristoylation activity was detected in brain
synaptosomes (64). In order to investigate whether MRP can be
myristoylated post-translationally, we have reconstituted an in
vitro myristoylation system consisting of purified unmyr MRP and
NMT as well as of [3H]myristoyl-CoA. Fig.
9 shows that unmyr MRP is myristoylated in the presence
of NMT. No labeling is present in the absence of NMT, demonstrating
that labeling is due to a covalent modification catalyzed by NMT. Also,
this modification is specific for the N terminus of MRP, since myr MRP
cannot be labeled (not shown). Similar results were obtained with human
MARCKS expressed in E. coli.3
These results suggest that, in vivo, nonmyristoylated pools
of MARCKS proteins can potentially be myristoylated
post-translationally. Since the activity present in brain requires
hours to significantly demyristoylate MARCKS proteins (8, 64),
post-translational myristoylation/demyristoylation cycles might
regulate long term cellular events in which MARCKS proteins are
involved.
In vitro myristoylation can also be used as a tool to investigate the structure of MRP. A quantification of the incorporation of the label shows that MRP is modified to near stoichiometry (0.5-0.7 nmol of myristate/nmol of MRP). Thus, the N terminus of MRP is accessible to NMT and exposed to the surface of the protein. A similar extent of labeling was obtained with MARCKS.3 Fig. 9 also demonstrates that binding of CaM to the PS domain of MRP does not change the ability of NMT to myristoylate MRP. A kinetic analysis shows that the rate of myristoylation is also not significantly altered by CaM (not shown). We can therefore exclude the possibility that the N terminus of MRP is at the interface of the MRP·CaM complex. Since PKC-dependent phosphorylation might change the conformation of MRP, we have also investigated the ability of the phosphorylated protein to serve as a substrate for NMT. As for the CaM·MRP complex, phosphorylation does not alter the myristoylation of MRP. Overall, these studies suggest that the N terminus is exposed to the surface of unmyr MRP and spatially separated from the PS domain. Whether this arrangement is still present in myr MRP or whether myristoylation induces a conformational change in MRP cannot be investigated with this technique. With respect to the myristoyl switch model (see Introduction), it would be interesting to determine whether myristoylation alters the relative positioning of the N terminus and the PS domain.
Effect of Divalent Cations on the Interactions of MRP with CaM and PKMGeorge and Blackshear (65) have observed that millimolar concentrations of Ca2+ and Mg2+ inhibit the binding of MARCKS, expressed in a cell-free system, to membranes isolated from fibroblasts. Since MARCKS proteins are acidic (pI < 4.5) (2), it would not be surprising that these proteins bind divalent cations. These cations could consequently modulate the interactions of MARCKS proteins with membranes or with other proteins. To investigate these aspects, we have measured the effects of Ca2+ and Mg2+ on the binding of MRP to CaM as well as on its phosphorylation by PKM.
Calmodulin contains four high affinity binding sites for
Ca2+ (Kd = 10
6 to
10
7 M). Ca2+ induces a large
conformational change that exposes hydrophobic residues on CaM and
allows its binding to target molecules (49, 50). In agreement with
these properties, half-maximum binding of a peptide corresponding to
the PS domain of MARCKS to CaM occurs with 0.4 µM
Ca2+ (66). Fig. 10A shows
titration curves of 30 nM CaMD with MRP in the
presence of various concentrations of Ca2+. Whereas MRP has
only a weak effect on the fluorescence of CaMD in the
absence of Ca2+, MRP binds to CaMD with high
affinity (kd,app = 24 nM) in
the presence of 0.1 mM CaCl2. Interestingly,
the affinity of the complex is decreased 6-fold as the concentration of
Ca2+ is increased to 1 mM
(Kd,app = 141 nM) and
17-fold as the Ca2+ concentration is raised to 10 mM (Kd,app = 400 nM). In an attempt to further characterize this effect, we
have titrated the CaMD·MRP complex with increasing
concentrations of Ca2+ and Mg2+. Since the
fluorescence of CaMD already depends on Ca2+
(not shown), the data were corrected for this effect by dividing by the
fluorescence of CaMD in the absence of MRP. Fig.
10B shows that Ca2+ and Mg2+
decrease the fluorescence signal in a
concentration-dependent manner. Both curves are identical,
demonstrating that the inhibitory effect of Ca2+ on the
complex formation between MRP and CaM is not specific to this cation.
Fig. 10C shows that Mg2+ has the same effect as
Ca2+ on the fluorescence of CaMD. The curves
measured in Fig. 10B must therefore reflect the properties
of the CaMD·MRP complex rather than of CaMD
alone.
), 0.1 mM CaCl2
(
), 1 mM CaCl2 (+), and 10 mM
CaCl2 (
). The data were fitted with hyperbolic functions
to determine the apparent dissociation constants. B, effect
of divalent cations (M2+) on the MRP-dependent
relative fluorescence increase of CaMD. A solution
containing 20 nM CaMD, 160 nM myr
MRP, and 0.1 mM CaCl2 was titrated with
increasing concentrations of MgCl2 (
). A solution
containing 20 nM CaMD and 160 nM
myr MRP was titrated with increasing concentrations of
CaCl2 (
). For each point the observed fluorescence was
corrected for the known dependence of CaMD fluorescence on
Ca2+ by dividing by
FCaM,Ca2+, the CaMD
fluorescence in the presence of the corresponding concentration of
Ca2+. Both curves were finally standardized by setting the
initial value of the titration (i.e. 0.1 mM
divalent cation) to 100%. C, effect of
Mg2+ on the relative fluorescence increase of
CaMD. A solution containing 20 nM
CaMD and 0.1 mM CaCl2 was titrated
with increasing concentrations of MgCl2 (
). The data
were corrected as described above and indicate that Mg2+
and Ca2+ affect identically the fluorescence of
CaMD.
To gain further insight into the effect of divalent cations on the
properties of MRP we have investigated whether Ca2+ can
also modulate the phosphorylation of MRP. Since PKM does not require
Ca2+ for its activation (53), an effect of Ca2+
on the phosphorylation of MRP should reflect a property of MRP rather
than PKM. Fig. 11 shows that the initial rate of
phosphorylation of myr MRP is inhibited by Ca2+ with a
half-maximum concentration of 2.7 mM, further supporting
the hypothesis that MRP binds Ca2+. However, this
conclusion is complicated by the observation that Ca2+ also
inhibits the phosphorylation of histone in the millimolar range (67).
Whether Ca2+ directly inhibits the activity of PKC or
rather binds to lipids or to the substrate was not investigated. In a
control experiment, we have also observed that
PKM-dependent phosphorylation of histone is inhibited by
Ca2+ in the same concentration range as for MRP (not
shown). Finally, in contrast to Ca2+, the phosphorylation
rate of MRP increases as the Mg2+ concentration is
increased with an estimated half-maximum concentration of 0.75 mM. This behavior simply reflects the requirement of the
catalytic site of PKM for Mg2+ (68).
, myr MRP and
CaCl2.
, myr MRP and MgCl2. The data were
fitted with sigmoidal functions to determine the
[M2+]0.5 concentrations.
In the absence of appropriate controls, we cannot determine whether the inhibitory effects seen in Figs. 10 and 11 result from the binding of divalent cations to MRP or to its binding partners CaM and PKM. The above studies therefore suggest, but do not demonstrate, that divalent cations bind to MARCKS proteins with millimolar affinities. What might be the biological significance of these observations? Although the putative affinity of Ca2+ for MRP is well above physiological concentrations, high Ca2+ intracellular concentrations (>0.1 mM) can be transiently reached close to Ca2+ channels (69). This property is used by proteins with low affinities for Ca2+ during synaptic vesicles exocytosis. For example, the binding of syntaxin to synaptotagmin-I requires more than 0.2 mM Ca2+ for half-maximum binding (70). The intracellular concentration of free Mg2+, on the other hand, is significantly higher than Ca2+ (0.5 mM) (71); binding of Mg2+ to MRP might therefore be physiologically relevant. To get definitive answers to these hypotheses, other techniques should be used that can directly detect and quantify the binding of such cations to MRP.
Effect of Myristoylation on the Properties of MRPSince the hydrophobic myristoyl moiety of MRP is unlikely to be exposed to the aqueous solvent, myristoylation could alter the conformation of the protein in solution. To investigate these aspects, most of the experiments described in this report were performed with both unmyr and myr MRP. None of these properties, i.e. the secondary structure of MRP, its phosphorylation by PKM, its binding to CaM, and the inhibitory effect of divalent cations, were significantly changed by myristoylation.
Sufficient quantities of myr MRP could not be purified to perform the analytical ultracentrifugation studies. We do not know, therefore, whether myristoylation changes the molecular dimensions of monomeric MRP and/or its oligomerization state. Also, the kinetics of binding of myr MRP to CaM were not investigated for the same reason. Although myr and unmyr MRP have the same affinity for CaM, myristoylation might modulate the mechanism of recognition of MRP by CaM and consequently alter the kinetics of complex formation. These experiments await the development of a better expression/purification system for myr MRP.
Taken together, our results show that myristoylation does not modulate the properties of MRP in solution. Since the myristoyl moiety of MRP is embedded in the membrane (8), myristoylation is certainly involved in the interactions of MRP with membranes but might also influence the interactions of MRP with other proteins at the membrane surface. In this respect, we have recently obtained evidence that myristoylation has an effect on the conformation of membrane-bound MRP.2
ConclusionIn this study we report a thorough characterization of the structure of MRP as well as of its interactions with CaM, PKM, NMT, and divalent cations in solution. Whether MRP binds to actin filaments has not yet been reported. A complete characterization of the in vitro properties of MRP will also require an understanding of its interactions with membranes (8, 9).2 Ultimately, protein-protein interactions involving MRP should be investigated at the membrane surface. Such studies will allow an analysis of the putative functions of MRP by answering the following questions: 1) can MRP sequestrate CaM at the membrane surface? 2) can MRP anchor actin filaments to the membrane? 3) what are the regulatory functions of PKC and Ca2+/CaM? 4) how is myristoylation involved in these interactions?
We express our thanks and gratitude to Christoph Stürzinger for purifying MRP and PKM. We are also grateful to Ariel Lustig for performing the analytical ultracentrifugation experiments and for stimulating discussions. We also thank Kate Young for invaluable technical assistance.